Literature DB >> 11553683

Overexpression of dopamine D2 receptors reduces alcohol self-administration.

P K Thanos1, N D Volkow, P Freimuth, H Umegaki, H Ikari, G Roth, D K Ingram, R Hitzemann.   

Abstract

The mechanism(s) underlying predisposition to alcohol abuse are poorly understood but may involve brain dopamine system(s). Here we used an adenoviral vector to deliver the dopamine D2 receptor (DRD2) gene into the nucleus accumbens of rats, previously trained to self-administer alcohol, and to assess if DRD2 levels regulated alcohol preference and intake. We show that increases in DRD2 (52%) were associated with marked reductions in alcohol preference (43%), and alcohol intake (64%) of ethanol preferring rats, which recovered as the DRD2, returned to baseline levels. In addition, this DRD2 overexpression similarly produced significant reductions in ethanol non-preferring rats, in both alcohol preference (16%) and alcohol intake (75%). This is the first evidence that overexpression of DRD2 reduces alcohol intake and suggests that high levels of DRD2 may be protective against alcohol abuse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553683     DOI: 10.1046/j.1471-4159.2001.00492.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  92 in total

1.  Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics.

Authors:  Terry Ritchie; Ernest P Noble
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

Review 2.  The addicted human brain: insights from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 3.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

4.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 5.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

Review 6.  Pharmacogenetic studies of alcohol self-administration and withdrawal.

Authors:  John C Crabbe; Tamara J Phillips
Journal:  Psychopharmacology (Berl)       Date:  2003-10-09       Impact factor: 4.530

Review 7.  Neurobiologic processes in drug reward and addiction.

Authors:  Bryon Adinoff
Journal:  Harv Rev Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.732

Review 8.  Optogenetic investigation of neural mechanisms for alcohol-use disorder.

Authors:  Barbara Juarez; Yutong Liu; Lu Zhang; Ming-Hu Han
Journal:  Alcohol       Date:  2018-06-19       Impact factor: 2.405

Review 9.  The gut in the brain: the effects of bariatric surgery on alcohol consumption.

Authors:  Ashley N Blackburn; Andras Hajnal; Lorenzo Leggio
Journal:  Addict Biol       Date:  2016-08-31       Impact factor: 4.280

10.  Early intervention of intravenous KB220IV--neuroadaptagen amino-acid therapy (NAAT) improves behavioral outcomes in a residential addiction treatment program: a pilot study.

Authors:  Merlene Miller; Amanda L C Chen; Stan D Stokes; Susan Silverman; Abdalla Bowirrat; Matthew Manka; Debra Manka; David K Miller; Kenneth Perrine; Thomas J H Chen; John A Bailey; William Downs; Roger L Waite; Margaret A Madigan; Eric R Braverman; Uma Damle; Mallory Kerner; John Giordano; Siobhan Morse; Marlene Oscar-Berman; Debmalya Barh; Kenneth Blum
Journal:  J Psychoactive Drugs       Date:  2012 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.